3,4,5-trihydroxybenzamidoxime

Known as: trimidox 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Graft-versus-host disease is the single most important obstacle facing successful allogeneic stem cell transplantation (SCT… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Gallic acid (GA) is a naturally occurring polyhydroxyphenolic compound and an excellent free radical scavenger. In this study, we… (More)
Is this relevant?
2006
2006
OBJECTIVE Clinically, the vascular pathobiology of human sickle cell disease includes an abnormal state of chronic inflammation… (More)
Is this relevant?
2004
2004
Resistance to cytotoxic nucleoside analogues is a major problem in cancer treatment. The cellular mechanisms involved in this… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To determine the role of oxidative stress in mediating HIV dementia and to identify novel therapeutic compounds that… (More)
  • figure 2
  • figure 1
  • figure 5
  • figure 6
Is this relevant?
2003
2003
Temozolomide (TMZ), an oral alkylating agent with good penetration of the blood-brain barrier, has shown efficacy in the… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2000
2000
Ribonucleotide reductase (RR) is the rate-limiting enzyme for the de novo synthesis of deoxyribonucleotides. Its activity is… (More)
Is this relevant?
2000
2000
Trimidox (3,4,5-trihydroxybenzohydroxamidoxime), a recently synthesized inhibitor of ribonucleotide reductase (RR), was shown to… (More)
Is this relevant?
1995
1995
Ribonucleotide reductase is the rate limiting enzyme of deoxynucleoside triphosphate synthesis and is considered to be an… (More)
  • figure 3
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?